文献速递甲状腺疾病

不一致甲状腺功能检测转诊病例诊断多样:关注淋巴增殖性疾病

Variable Diagnoses in Cases Referred for Discordant Thyroid Function Tests: Focus on Lymphoproliferative Disorders.
PubMed 文献 · Thyroid · 2025-07-30

该回顾性横断面研究纳入144例因疑似中枢性甲亢转诊的不一致甲状腺功能检测患者,发现44%为真实罕见甲状腺疾病(32%为RTHβ),56%为检测干扰。在干扰组中6/81检出克隆性副蛋白,其中1例多发性骨髓瘤、1例惰性边缘区B细胞非霍奇金淋巴瘤相关1型冷球蛋白血症,4例意义未明单克隆丙种球蛋白病。

要点

  • 不一致TFTs患者中RTHβ最常见,但检测干扰更普遍。
  • 检测干扰组中克隆性副蛋白可提示淋巴增殖性疾病。
  • 推荐对干扰病例进行血清蛋白电泳和血液学检查。

核心结论

  • 不一致TFTs转诊患者中RTHβ是最常见的甲状腺疾病,但检测干扰是最常见的总体情况。
  • 检测干扰病例中应高度推荐血清蛋白电泳和血液学检查以发现淋巴增殖性疾病。

研究设计与样本

  • 回顾性横断面研究,纳入2017年1月至2025年2月连续转诊至内分泌与代谢病科的可疑中枢性甲亢患者144例。

主要发现

  • 144例中44%为真实罕见甲状腺疾病:32%为RTHβ,7%为TSH分泌腺瘤,5%为其他诊断。
  • 56%存在检测干扰,其中6/81检出干扰性克隆性副蛋白。
  • 6例中1例多发性骨髓瘤,1例惰性边缘区B细胞非霍奇金淋巴瘤相关1型冷球蛋白血症,4例意义未明单克隆丙种球蛋白病。
  • 克隆性副蛋白为IgM kappa/lambda者5例,IgG kappa或IgA kappa者各1例。

关键数值与推荐

  • 纳入标准包括:TSH升高或不适当正常伴FT4和/或FT3升高;TSH升高伴FT4处于参考范围上限;左甲状腺素治疗下TSH未正常化且FT4升高。
  • 鉴别诊断方法包括不同分析方法和串联质谱复测、血清系列稀释或PEG沉淀、类风湿因子/SPEP/冷球蛋白评估及深度临床表型和/或基因检测。

临床怎么用

  • 对疑似中枢性甲亢的不一致TFTs患者,应系统排查检测干扰。
  • 检测干扰病例中应行SPEP和血液学检查以筛查淋巴增殖性疾病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Careful consideration of the differential diagnosis of discordant thyroid function tests (TFTs) is fundamental to prevent mismanagement, waste of resources, uncover rare thyroid disorders, or other underlying critical conditions in patients referred for the evaluation of this issue. Here, we describe the frequency of underlying diagnoses and focus on cases in which the identification of analytical interferences led to the discovery of lymphoproliferative disorders. Methods: This is a retrospective cross-sectional study including all consecutive patients referred to the Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano, for suspected central hyperthyroidism between January 2017 and February 2025. Inclusion criteria were based on laboratory findings of (1) elevated or inappropriately normal thyrotropin (TSH) with high FT4 and/or FT3, (2) elevated TSH with FT4 in the upper reference range, and (3) failure of TSH to normalize despite levothyroxine therapy, along with rising FT4 levels. The differential diagnosis was made by (1) reassessment of discrepant results in the hormone panel by different analytical methods or tandem mass spectrometry; (2) serum serial dilution or polyethylene glycol precipitation; (3) evaluation of rheumatoid factor, serum protein electrophoresis (SPEP), and cryoglobulins; and (4) deep clinical phenotyping and/or confirmatory genetic testing, as appropriate. Results: Among 144 patients referred for discordant TFTs mimicking central hyperthyroidism, 44% were genuine rare thyroid disorders-32% with resistance to thyroid hormone beta (RTHβ), 7% with TSH-secreting adenomas, and 5% other diagnosis-and 56% had assay interference. In this latter group, interfering clonal paraproteins were detected in 6/81 cases. One patient was ultimately diagnosed with multiple myeloma, another one with type 1 cryoglobulinemia due to indolent marginal zone B non-Hodgkin lymphoma, and the remaining four cases were found to have monoclonal gammopathy of uncertain significance. The clonal paraprotein was an IgM kappa/lambda in five cases and IgG kappa or IgA kappa in one case, respectively. Conclusions: In patients referred for discordant TFTs, RTHβ is the most prevalent thyroid disorder, but variable assay interferences represent the most frequent condition. In these cases, SPEP and hematological investigations are highly recommended.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Musolino A, Grifoni GFA, Rodolfi S, et al. Variable Diagnoses in Cases Referred for Discordant Thyroid Function Tests: Focus on Lymphoproliferative Disorders. Thyroid. 2025. PMID: 40737226. doi:10.1177/10507256251364557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。